Video to Promote HPV Vaccination
Study Details
Study Description
Brief Summary
The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens.
Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Vaccine Information Statement Study participants will receive the HPV Vaccine Information Statement (VIS) which is part of routine care. |
|
Experimental: Video & Vaccine Information Statement Participants will view an educational video about the HPV vaccine with a male or female narrator. Participants will also receive the HPV Vaccine Information Statement (VIS) which is part of routine care. |
Other: Educational Video with Male or Female Narrator
Participants will watch an educational video about the quadrivalent HPV vaccine (Gardasil) narrated by either a male or female.
|
Outcome Measures
Primary Outcome Measures
- HPV Vaccination Series Initiation [90 days]
Number of HPV vaccine doses received among study participants
- HPV Vaccine Series Initiation [0 days]
HPV Vaccine Receipt among study participants
Secondary Outcome Measures
- HPV Vaccine Series Initiation (depending on male versus female narrator) [0 days]
Difference in rate of HPV vaccine receipt between study participants who viewed a video narrated by a male versus a female
- HPV Vaccine Series Initiation (depending on male versus female narrator) [90 days]
Difference in number of HPV vaccine doses between study participants who viewed a video narrated by a male versus a female
Other Outcome Measures
- HPV Vaccine Awareness [0 days]
Reported reason for HPV vaccine receipt or deferral
Eligibility Criteria
Criteria
Inclusion Criteria:
- Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine
Exclusion Criteria:
-
Parent-child dyads in which the child has received the HPV vaccine
-
Parent-child dyads in which the child is older than 18 at the time of enrollment
-
Non-English speakers
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Primary Care, Flourtown, Children's Hospital of Philadelphia | Flourtown | Pennsylvania | United States | 19031 |
2 | Nicholas and Athena Karabots Pediatric Care Center | Philadelphia | Pennsylvania | United States | 19139 |
Sponsors and Collaborators
- Children's Hospital of Philadelphia
- Noble Medical, LLC
Investigators
- Principal Investigator: Kristen A. Feemster, MD MPH MSHP, Children's Hospital of Philadephia
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRB 14-011091